(secondQuint)PALISADE Follow-on Study (ARC004).

 This is an international, multicenter, open-label, 2-arm follow-on study of the safety, tolerability, and efficacy of AR101 in peanut-allergic individuals who have completed the ARC003 study.

 This study will explore alternative dosing regimens during extended maintenance with AR101.

.

 PALISADE Follow-on Study (ARC004)@highlight

The purpose of this study is to demonstrate the safety, tolerability, and efficacy of AR101 through characterized oral desensitization immunotherapy (CODIT) in peanut-allergic children and adults who have completed the ARC003 study.

